The Latest Insights from Yanne Capital

Yanne Capital regularly publishes in-depth strategic insights on the trends shaping how growth-stage companies raise capital and transact. Our research is sector-agnostic by design. Rather than focusing on a single vertical, it draws on activity across the 26 sectors we cover and across equity, debt, and M&A, which lets us see where capital is actually moving instead of where the headlines point. That perspective is a direct result of completing 240+ transactions and maintaining relationships with 3,500+ institutional investors globally. Follow Yanne Capital on LinkedIn for ongoing updates, and subscribe to our research to receive new releases as they publish.

Each report examines a specific corner of the growth-stage capital markets and is written to be useful to founders, boards, investors, and the advisers who sit alongside them. Our research team keeps each report current, updating the facts, data, and transaction activity as the market moves, so the version published here reflects our most up-to-date view. The latest version of each report appears below, along with a brief overview of its contents.

For institutional and professional use only.

Yanne Capital | Research & Insights

Q1 2026 Credit Markets Retrospective and Q2 Forward View

Private credit AUM closed Q1 2026 near 1.9 trillion dollars globally, but the headline understates what actually happened inside the quarter.

Read Now

Capital Structure 2027: Founder Forward Plan

The lower middle market enters H2 2026 carrying three simultaneous pressures: credit conditions tightening for four consecutive quarters per the OECD Lending Standards survey, LP a

Vertical SaaS & Tech-Enabled B2B M&A

The vertical SaaS M&A market in H1 2026 decoupled from horizontal software in a way generalist coverage largely missed.

Distressed Debt and Restructuring: H2 Watch

H2 2026 is the first stretch in this cycle where the private credit book gets tested against covenants written during the 2021-2022 vintage

The 12-Week M&A Sale-Side Process: Operator's Map

Lower middle-market M&A sale-side processes run on a compressed, non-linear rhythm where decisions made in the first three weeks constrain every option available in the last three.

The Debt-First Capital Stack: Founder's Toolkit

For a decade, the default growth-stage capital sequence was equity first, debt later. That sequence made sense when equity was cheap. At current rates, the fully-loaded cost of a d

Q2 2026 Lower Middle Market Capital Outlook

The lower middle market enters H2 2026 carrying three simultaneous pressures: credit conditions tightening for four consecutive quarters per the OECD Lending Standards survey, LP a

Healthcare AI Equity Trajectory

Healthcare AI sits at the intersection of two of this cycle's largest capital flows. Growth-stage healthcare AI rounds in 2025 closed at a median 9.2x forward ARR multiple, against

Founder Liquidity Without IPO: Secondary Tender Structures

The median time from Series A to IPO has stretched from 6.9 years in 2014 to 10.7 years in 2025 (PitchBook US Venture Monitor, Q1 2026), and the share of unicorns aged eight years

Defense Tech Capital Stack H2 2026

Defense tech raised 40.1B in venture capital across 626 deals in 2024, more than triple the 12.8B raised in 2019 (PitchBook, Q1 2026). The headline obscures a more interesting stru

Sovereign Capital Q3 2026 Update

How Sovereign Capital Is Reshaping Growth-Stage Fundraising

Vertical AI Capital Trajectory H2 2026

How Vertical AI Became the Dominant Growth-Stage Capital Destination

Family Office Allocation Shift: H2 2026 Watch

How Family Offices Are Reshaping Growth-Stage Fundraising

How Growth-Stage Founders Are Rebuilding the Capital Stack with Venture Debt in 2026

How Venture Debt Became a Structural Layer of the Growth-Stage Capital Stack

The Down-Round Playbook H2 2026 Edition

How Down Rounds Became a Structural Growth-Stage Financing Playbook

The 14-Week Growth-Round Equity Process Map

How the 14-Week Growth-Round Became the New Equity Process Standard

Pharma's Patent Cliff, 1.3 Trillion in Deal Capacity, and the Reset in Life-Sciences Capital

How Pharma’s Patent Cliff Reopened the Life-Sciences Capital Window

The Climate Capital Reset

How Climate Capital Repriced Around Offtakes, Structure, and Longer Fundraises

Your Next Deal Starts With a Conversation

Reach out to our advisory team and schedule a confidential discussion with our team to explore capital raising, M&A, or debt advisory for your business.